Monotherapy versus Multi-Drug Therapy for the Treatment of Perforated Appendicitis in Children
- 1 December 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Surgical Infections
- Vol. 4 (4), 327-333
- https://doi.org/10.1089/109629603322761382
Abstract
Background: Children with perforated appendicitis often have a prolonged hospital course complicated by surgical site or intra-abdominal infections. Treatment with multiple intravenous (IV) antibiotics after appendectomy has been the standard of care for these patients. We have recently adopted a protocol using piperacillin-tazobactam (PT) as a single agent in lieu of the standard multi-drug regimen (MD). We hypothesized that PT would be as effective as MD in reducing postoperative complications and would result in decreased resource utilization. Methods: We reviewed the medical records of all children admitted to our hospital between January 1, 1998 and December 31, 2001 with the diagnosis of perforated appendicitis. Patients who underwent operation within the first 24 h of admission were divided into two groups based on their antibiotic regimen: PT versus MD. Demographic data, duration of presenting symptoms, initial WBC, length of stay, and infectious complications were abstracted. Categorical data were compared using Chi square analysis; continuous variables were compared using Student's t-test when the data were normally distributed and the Mann-Whitney U test when the data were skewed. Results: There was no difference between the PT (n = 51) and MD (n = 43) groups with respect to age, duration of presenting symptoms, initial WBC, or length of hospital stay. However, patients in the MD group had a significantly higher overall complication rate than those in the PT group (14/43 vs. 4/51, p = 0.002). Antibiotic-related complications including surgical site infections, venous catheter-related infections, intra-abdominal abscesses, and drug reactions were also higher in the MD group (10/43 vs. 4/51, p = 0.04). The outpatient charges for each patient based on an average of seven days of home antibiotics were $2,460 for the PT group and $4,349 for the MD group. Conclusions: Children with perforated appendicitis can be managed effectively with a single broad-spectrum antibiotic after appendectomy. Monotherapy is not only more efficacious than multi-drug therapy, but may be more cost effective. The use of monotherapy for children with perforated appendicitis after adequate source control should be considered the treatment of choice.Keywords
This publication has 8 references indexed in Scilit:
- Current practice patterns in the treatment of perforated appendicitis in childrenJournal of the American College of Surgeons, 2003
- Oral Antibiotics in the Management of Perforated Appendicitis in ChildrenThe American Surgeon, 2002
- The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: An Executive SummarySurgical Infections, 2002
- Results of a Pilot Trial Comparing Prolonged Intravenous Antibiotics With Sequential Intravenous/Oral Antibiotics for Children With Perforated AppendicitisArchives of Surgery, 2001
- Complicated Appendicitis: Is There a Minimum Intravenous Antibiotic Requirement? A Prospective Randomized TrialThe American Surgeon, 2000
- Perforated appendicitis: Prospective outcome analysis for 150 childrenJournal of Pediatric Surgery, 2000
- Management of perforated appendicitis in children: A decade of aggressive treatmentJournal of Pediatric Surgery, 1994
- The treatment of complicated appendicitis in children using peritoneal drainage: Results from a public hospitalJournal of Pediatric Surgery, 1993